For more information and details about eligibility and restrictions, visit or
Yes low fiber, dysbiosis, or inflammation reduces SCFAs, weakening GLP-1 output and increasing hunger and cravings
When used with insulin or sulfonylureas, there is an increased risk of hypoglycaemia, and dose reduction of these medications may be needed
Green Edition: Carbonated Water, Sucrose, Glucose, Citric Acid, Taurine, Natural and Artificial Flavors, Sodium Citrate, Caffeine, Colors, Niacinamide, Pyridoxine HCI, Calcium Pantothenate, Ascorbic Acid, Vitamin B12
Some GLP-1 medications have demonstrated cardiovascular benefits in clinical trials (such as LEADER for liraglutide, SUSTAIN-6 for semaglutide, and REWIND for dulaglutide), and discontinuation may result in loss of these protective effects
Complete clearance typically occurs four to five weeks after your final injection, though trace amounts may linger slightly longer in some individuals